Trial Profile
Appraisal of MDCO-157 and Plavix Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Open-label, Randomized, Cross-over Evaluation: The AMPHORE Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Clopidogrel (Primary)
- Indications Coronary thrombosis
- Focus Pharmacodynamics
- Acronyms AMPHORE
- Sponsors The Medicines Company
- 19 Sep 2015 Results published in the American Journal of Cardiovascular Drugs.
- 24 May 2013 New trial record